Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brain Substrates of Hypoglycemia Unawareness
NCT02866435Phase 1Completed
- Sponsor
- University of Minnesota
- Start
- Nov 2016
- Primary completion
- Sep 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of human insulin in type 1 diabetes mellitus (T1D), sponsored by University of Minnesota. Primary endpoints: Functional connectivity and Cerebral blood flow. Started Nov 2016; status: completed.
02
Drugs
human insulin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02866435.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02866435.